Register or Sign in to Save this opportunity, or Send an Inquiry.
Bilosomes: Novel Vehicles for Oral Delivery of Drugs
Health Technologies at Strathclyde United Kingdom flag United Kingdom
Abstract ID:
Bile salt stabilised vesicles that act as an envelope to protect their contents from the harsh environment of the gut enabling oral administration.
Send an Inquiry
RE:
Participants
You

Background


Oral administration remains the favoured method of drug delivery by patients. For a drug to be successfully absorbed by the body it requires the active molecule to transit through the stomach and then to be transferred across the intestinal wall to the bloodstream. For a majority of vaccines and biologic therapeutics this is not an option due to a 1% uptake of the dose given.


Approximately 1/3 of small molecule drugs also face oral absorption challenges many of these are focussed on CNS targets.


Technology


Scientists at Strathclyde have developed Bilosomes, bile salt stabilised vesicles that act as an envelope to protect their contents from the harsh environment of the gut enabling oral administration. The system was well tolerated in in vivo toxicology studies.


Key Benefits


GO PREMIUM TO GET PATENT INFORMATION
Type of Business Relationship Sought

Contact is welcomed from organisations interested in developing, licensing or exploiting this technology.

FEATURED
Last Updated Oct 2014
Technology Type
Phase of Development EARLY STAGE
UNIVERSITY

Opportunity Contact